(Q33543374)

27 July 2017

A Canadian naturalistic study of a community-based cohort treated for bipolar disorder (English)

1 reference

27 July 2017

1 reference

Doron Sagman

1

1 reference

27 July 2017

Bobbie Lee

2

1 reference

27 July 2017

Ranjith Chandresena

3

1 reference

27 July 2017

Barry Jones

4

1 reference

27 July 2017

Elizabeth Brunner

5

1 reference

27 July 2017

19 March 2010

1 reference

27 July 2017

1 reference

27 July 2017

10

1 reference

27 July 2017

24

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

start time

19 March 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-244x-10-24

0 references

cites work

Treatment of bipolar disorder: the evolving role of atypical antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Quality of life in bipolar disorder: a review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Olanzapine alone or in combination for acute mania

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

A comparison of observational studies and randomized, controlled trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

An inventory for measuring clinical anxiety: psychometric properties

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

A rating scale for mania: reliability, validity and sensitivity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

A New Depression Scale Designed to be Sensitive to Change

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Polytherapy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-10-24

Bipolar disorder: quality of life and the impact of atypical antipsychotics.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

Advanced statistics: the propensity score--a method for estimating treatment effect in observational research.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2851681

31 October 2018

Identifiers

DOI

10.1186/1471-244X-10-24

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-10-24

9 September 2019

1 reference

27 July 2017

1 reference